95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-19.93%
Negative revenue growth while RGLD stands at 29.53%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-17.34%
Negative gross profit growth while RGLD is at 423.72%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.55%
Negative EBIT growth while RGLD is at 28.40%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.55%
Negative operating income growth while RGLD is at 28.40%. Joel Greenblatt would press for urgent turnaround measures.
-15.36%
Negative net income growth while RGLD stands at 20.41%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-15.00%
Negative EPS growth while RGLD is at 19.08%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-15.00%
Negative diluted EPS growth while RGLD is at 16.73%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.05%
Share reduction more than 1.5x RGLD's 1.90%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.12%
Diluted share reduction more than 1.5x RGLD's 1.89%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-44.44%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-25.60%
Negative OCF growth while RGLD is at 36.37%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-394.81%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
474.43%
10Y revenue/share CAGR at 75-90% of RGLD's 625.31%. Bill Ackman would press for new markets or product lines to narrow the gap.
155.90%
5Y revenue/share CAGR at 75-90% of RGLD's 201.02%. Bill Ackman would encourage strategies to match competitor’s pace.
104.72%
3Y revenue/share CAGR similar to RGLD's 103.19%. Walter Schloss would assume both companies experience comparable short-term cycles.
318.78%
10Y OCF/share CAGR at 50-75% of RGLD's 443.77%. Martin Whitman might fear a structural deficiency in operational efficiency.
198.21%
5Y OCF/share CAGR above 1.5x RGLD's 95.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
151.07%
3Y OCF/share CAGR 1.25-1.5x RGLD's 125.36%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
2734.24%
Net income/share CAGR above 1.5x RGLD's 444.89% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
292.06%
5Y net income/share CAGR above 1.5x RGLD's 116.21%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
215.81%
3Y net income/share CAGR above 1.5x RGLD's 136.88%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
3071.55%
10Y equity/share CAGR above 1.5x RGLD's 1268.69%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
146.06%
5Y equity/share CAGR at 75-90% of RGLD's 172.56%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
59.98%
3Y equity/share CAGR at 75-90% of RGLD's 68.05%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
51.09%
Our AR growth while RGLD is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-0.34%
Negative asset growth while RGLD invests at 1.14%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.54%
Positive BV/share change while RGLD is negative. John Neff sees a clear edge over a competitor losing equity.
-11.10%
We’re deleveraging while RGLD stands at 0.75%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-8.05%
We cut SG&A while RGLD invests at 35.40%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.